Testing effectiveness (Phase 2)Study completedNCT05509699
What this trial is testing
Surufatinib Plus Anti-PD-1/L1 as Maintenance Therapy in Extensive-Stage Small Cell Lung Cancer
Who this might be right for
Extensive-Stage Small Cell Lung Cancer
Hutchison Medipharma Limited 21